Press Releases Keyword Search Year None202120202019201820172016201520142013 Jan 19, 2021 Seres Therapeutics to Present SER-109 Phase 3 Mechanistic Data at Keystone Symposium Jan 06, 2021 Seres Therapeutics Publishes Positive SER-287 Phase 1b Ulcerative Colitis Study Results in Journal Gastroenterology Jan 06, 2021 Seres Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
Jan 06, 2021 Seres Therapeutics Publishes Positive SER-287 Phase 1b Ulcerative Colitis Study Results in Journal Gastroenterology
